STAT+: FDA adcomm members’ ties to industry under scrutiny

Summary

Research reveals that nearly 40% of FDA advisory committee meetings over a 20-year period included patient or consumer representatives with active ties to industry advocacy groups, raising concerns about conflicts of interest.